Literature DB >> 22580256

Virtual and real bench testing of a new percutaneous valve device: a case study.

Giovanni Biglino1, Claudio Capelli, Alia Binazzi, Rita Reggiani, Daria Cosentino, Francesco Migliavacca, Philipp Bonhoeffer, Andrew M Taylor, Silvia Schievano.   

Abstract

AIMS: To validate patient-specific computational testing of a second-generation device for percutaneous pulmonary valve implantation (PPVI), against realistic in vitro data. METHODS AND
RESULTS: Tests were initially carried out in a simple loading mode, performing a compliance test on a rapid prototyped cylinder. This model was reproduced computationally and validated against the experimental data. A second-generation PPVI stent-graft, with no valve mounted, was then deployed in a simplified cylindrical geometry, measuring its displacement when subjected to a pressure pulse. Experimental and computational measurements were in good agreement. Finally, having selected a patient regarded as unsuitable for first-generation PPVI, but potentially suitable for a second-generation device, the stent-graft was studied in the rapidly prototyped patient-specific right ventricular outflow tract (RVOT). Stent positioning and radial displacements with pulsatile flow were observed in a mock circuit using fluoroscopy imaging. Stent deformation and anchoring were measured both in vitro and computationally. Both tests indicated that the stent was well anchored in the RVOT, especially in the distal position, and its central region was rounded, ensuring, were a valve present, optimal valve function.
CONCLUSION: We suggest that an experimentally validated computational model can be used for preclinical device characterisation and patient selection.

Entities:  

Mesh:

Year:  2012        PMID: 22580256     DOI: 10.4244/EIJV8I1A19

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

Review 1.  Computer modeling to tailor therapy for congenital heart disease.

Authors:  Michael A Quail; Andrew M Taylor
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 2.  Cardiac 3D Printing and its Future Directions.

Authors:  Marija Vukicevic; Bobak Mosadegh; James K Min; Stephen H Little
Journal:  JACC Cardiovasc Imaging       Date:  2017-02

3.  Rapid prototyping compliant arterial phantoms for in-vitro studies and device testing.

Authors:  Giovanni Biglino; Peter Verschueren; Raf Zegels; Andrew M Taylor; Silvia Schievano
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-16       Impact factor: 5.364

Review 4.  Modeling single ventricle physiology: review of engineering tools to study first stage palliation of hypoplastic left heart syndrome.

Authors:  Giovanni Biglino; Alessandro Giardini; Tain-Yen Hsia; Richard Figliola; Andrew M Taylor; Silvia Schievano
Journal:  Front Pediatr       Date:  2013-10-30       Impact factor: 3.418

5.  Numerical model of a valvuloplasty balloon: in vitro validation in a rapid-prototyped phantom.

Authors:  Benedetta Biffi; Giorgia M Bosi; Valentina Lintas; Rod Jones; Spyros Tzamtzis; Gaetano Burriesci; Francesco Migliavacca; Andrew M Taylor; Silvia Schievano; Giovanni Biglino
Journal:  Biomed Eng Online       Date:  2016-04-12       Impact factor: 2.819

Review 6.  Role of innovative 3D printing models in the management of hepatobiliary malignancies.

Authors:  Peter Bangeas; Vassilios Tsioukas; Vasileios N Papadopoulos; Georgios Tsoulfas
Journal:  World J Hepatol       Date:  2019-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.